Objective: Endothelin converting enzyme is the key enzyme in the generation
of endothelin-l from big-endothelin-l. The mature endothelin-l is a potent
vasoconstrictor which also promotes mitogenesis and proliferation of smoot
h muscle cells. The objectives were to demonstrate in smooth muscle cells t
he presence of a phosphoramidon-sensitive endothelin converting enzyme acti
vity, reveal the subcellular localization of the enzyme protein and determi
ne the effects of the metalloproteinase inhibitor, phosphoramidon, the lyso
somotrophic drug, chloroquine, and colchicine on the cycling pathway of the
enzyme. Methods: Subcellular localization of endothelin converting enzyme
on human smooth muscle cells and the rat cell line, A7r5, was by immunofluo
rescence and confocal microscopy or by biotinylation of cell cultures and i
mmunoblotting, after treatment of cell cultures with cytochalasin D, colchi
cine, chloroquine and phosphoramidon. Converting enzyme activity was determ
ined by high performance liquid chromatographic assay. Results: We detected
phosphoramidon-sensitive endothelin converting enzyme activity in smooth m
uscle cells. In addition to its plasma membrane location, for the first tim
e we revealed a striking co-localization of endothelin converting enzyme an
d a-actin filaments in smooth muscle cells. Colchicine treatment results in
a perinuclear accumulation of endothelin converting enzyme. An increased l
evel of endothelin converting enzyme protein was shown to be present in smo
oth muscle cells which had been grown in the presence of phosphoramidon or
chloroquine. Conclusion: The 120 kDa endothelin converting enzyme co-locali
zes with ol-actin in smooth muscle cells and resembles that found in endoth
elial cells in that it is present on both the plasma membrane and intracell
ularly. (C) 1999 Elsevier Science B.V. All rights reserved.